233 related articles for article (PubMed ID: 19346028)
1. Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Duruisseaux M; Cadranel J; Biron E; Pérol M; Guérin JC; Arpin D
Lung Cancer; 2009 Sep; 65(3):385-7. PubMed ID: 19346028
[TBL] [Abstract][Full Text] [Related]
2. Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung.
Omlin A; D'Addario G; Gillessen S; Cerny T; von Hessling A; Früh M
Lung Cancer; 2009 Sep; 65(3):383-4. PubMed ID: 19375814
[TBL] [Abstract][Full Text] [Related]
3. The role of pemetrexed in lung adenocarcinoma, mixed subtype with bronchioloalveolar carcinoma features.
Duruisseaux M; Cadranel J; Pérol M; Arpin D
Curr Drug Targets; 2010 Jan; 11(1):74-7. PubMed ID: 19839924
[TBL] [Abstract][Full Text] [Related]
4. Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma.
Lau DH; Moon J; Davies AM; Sanborn RE; Hirsch FR; Franklin WA; Ruzich JC; Redman MW; Gandara DR
Clin Lung Cancer; 2013 Jul; 14(4):351-5. PubMed ID: 23415808
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer.
Ohe Y; Ichinose Y; Nakagawa K; Tamura T; Kubota K; Yamamoto N; Adachi S; Nambu Y; Fujimoto T; Nishiwaki Y; Saijo N; Fukuoka M
Clin Cancer Res; 2008 Jul; 14(13):4206-12. PubMed ID: 18594001
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with pemetrexed in a patient with mucinous bronchioloalveolar carcinoma: long-term response duration with mild toxicity.
Okuda C; Kim YH; Takeuchi K; Togashi Y; Masago K; Sakamori Y; Mio T; Mishima M
J Thorac Oncol; 2011 Mar; 6(3):641-2. PubMed ID: 21317746
[No Abstract] [Full Text] [Related]
9. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
Wislez M; Antoine M; Baudrin L; Poulot V; Neuville A; Pradere M; Longchampt E; Isaac-Sibille S; Lebitasy MP; Cadranel J
Lung Cancer; 2010 May; 68(2):185-91. PubMed ID: 19581016
[TBL] [Abstract][Full Text] [Related]
10. Response to pemetrexed chemotherapy in lung adenocarcinoma-bronchioloalveolar carcinoma insensitive to erlotinib.
Manson GV; Ma PC
Clin Lung Cancer; 2010 Jan; 11(1):57-60. PubMed ID: 20085869
[TBL] [Abstract][Full Text] [Related]
11. [Study of use of pemetrexed in non-small cell lung cancer].
Villanueva-Herraiz S; Ortega-García MP; Camps-Herrero C; Blasco-Segura P
Farm Hosp; 2010; 34(4):194-203. PubMed ID: 20594885
[TBL] [Abstract][Full Text] [Related]
12. Interstitial pneumonitis after treatment with pemetrexed: a rare event?
Hochstrasser A; Benz G; Joerger M; Templeton A; Brutsche M; Früh M
Chemotherapy; 2012; 58(1):84-8. PubMed ID: 22377772
[TBL] [Abstract][Full Text] [Related]
13. [Safety of pemetrexed according to the duration of vitamin B12 and folic acid supplementation prior to the first dose of pemetrexed].
Tsuda Y; Kitamura A; Nishimura N; Yagi N; Takayama S; Okafuji K; Tomishima Y; Jinta T; Koyama K; Ohde S; Gotoh K; Chohnabayashi N
Gan To Kagaku Ryoho; 2015 Apr; 42(4):471-5. PubMed ID: 25963695
[TBL] [Abstract][Full Text] [Related]
14. [Update of pemetrexed in thoracic oncology].
Brechot JM; Morère JF
Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
[TBL] [Abstract][Full Text] [Related]
15. Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations.
Wu SG; Yang CH; Yu CJ; Lee JH; Hsu YC; Chang YL; Shih JY; Yang PC
Lung Cancer; 2011 Jun; 72(3):333-9. PubMed ID: 21111508
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed in first-line treatment of non-small cell lung cancer.
Esteban E; Casillas M; Cassinello A
Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
[TBL] [Abstract][Full Text] [Related]
17. [Other thoracic cancers. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar carcinoma feature: a clinico-pathological spectrum].
Cadranel J; Lavolé A; Gounant V; Wislez M
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S196-202. PubMed ID: 18971846
[TBL] [Abstract][Full Text] [Related]
18. A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.
Grønberg BH; Bremnes RM; Aasebø U; Brunsvig P; Fløtten O; Amundsen T; von Plessen C; Wang M; Sundstrøm S;
Lung Cancer; 2009 Jan; 63(1):88-93. PubMed ID: 18538889
[TBL] [Abstract][Full Text] [Related]
19. A favorable response to cisplatin, pemetrexed and bevacizumab in two cases of invasive mucinous adenocarcinoma formerly known as pneumonic-type mucinous bronchioloalveolar carcinoma.
Yamakawa H; Takayanagi N; Ishiguro T; Kagiyama N; Shimizu Y; Sugita Y
Intern Med; 2013; 52(24):2781-4. PubMed ID: 24334585
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed-induced edema of the eyelid.
Kurata T; Tamura K; Okamoto I; Satoh T; Nakagawa K; Fukuoka M
Lung Cancer; 2006 Nov; 54(2):241-2. PubMed ID: 16996165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
